By TrivBits, History Desk — Published November 2, 2026

Table of Contents

• Key Takeaways
• The Inventor of the Lobotomy and the Nobel Prize Era
• How the Procedure Spread Across Civilizations
• The Devastating Legacy of a Nobel-Winning Innovation
• The Nobel Prize Controversy Through History
• Frequently Asked Questions
• Sources

Medical history is filled with treatments that seemed brilliant at the time but horrifying in retrospect. The lobotomy stands as one of the most chilling examples. Even more shocking? The inventor of the lobotomy, Portuguese neurologist António Egas Moniz, won the Nobel Prize in Physiology or Medicine in 1949 for developing this procedure. The award recognized what was then considered a breakthrough in treating severe mental illness, though the practice would later become synonymous with medical barbarism.

This dark chapter in twentieth-century medicine reveals how even the most prestigious scientific honors can be awarded for innovations that history ultimately condemns. The story spans continents and decades, intertwining ambition, desperation, and the evolving understanding of the human brain.

Key Takeaways

• António Egas Moniz developed the prefrontal leucotomy (lobotomy) in 1935 and received the Nobel Prize for it in 1949.
• The procedure involved severing connections in the brain’s prefrontal cortex to treat severe mental illness and intractable pain.
• Tens of thousands of lobotomies were performed worldwide, particularly in the United States during the 1940s and 1950s.
• The procedure often left patients in vegetative states or with severe personality changes and cognitive impairment.
• The lobotomy fell out of favor by the 1960s as antipsychotic medications became available and ethical concerns mounted.
• The Nobel Prize awarded to Moniz remains controversial and has never been rescinded.

The Inventor of the Lobotomy and the Nobel Prize Era

António Egas Moniz was already an accomplished Portuguese physician when he turned his attention to psychiatry in his later years. Born in 1874, he had served as a diplomat and politician before dedicating himself fully to neurology. In the early twentieth century, psychiatric treatment options were dismally limited. Asylums warehoused patients with schizophrenia, severe depression, and other conditions with little hope of recovery.

Moniz believed that mental illness originated from fixed patterns of thought physically lodged in the brain’s neural pathways. His solution? Destroy those pathways. In 1935, he performed his first leucotomy procedure, using alcohol injections to destroy tissue in the frontal lobes. He later refined the technique to involve cutting white matter connections. The results seemed promising to observers of that era—some patients appeared calmer, less tormented by their symptoms.

The Nobel Committee awarded Moniz the prize “for his discovery of the therapeutic value of leucotomy in certain psychoses.” This recognition came at a time when the medical community was desperate for any intervention that might help severely ill psychiatric patients. The award reflected the values and knowledge limitations of mid-century medicine rather than timeless scientific achievement.

How the Procedure Spread Across Civilizations

American neurologist Walter Freeman became lobotomy’s most zealous promoter. He modified Moniz’s technique into the transorbital lobotomy—a procedure so simple it could be performed in a doctor’s office without a surgical suite. Freeman inserted an ice pick-like instrument through the eye socket, swept it back and forth to sever frontal lobe connections, and completed the entire operation in minutes.

Freeman traveled across the United States in a vehicle he called his “lobotomobile,” performing thousands of procedures. He trained other physicians in the technique, spreading it throughout American medical institutions. By the mid-1950s, approximately 40,000 to 50,000 lobotomies had been performed in the United States alone. Thousands more occurred in Europe, Japan, and other nations.

The procedure was applied broadly—sometimes appropriately for severe, treatment-resistant conditions, but often for depression, anxiety, or even troublesome behavior. Women received lobotomies more frequently than men. Some patients were children. The ease of the procedure and the promise of managing difficult patients made it attractive to overcrowded psychiatric institutions.

The Devastating Legacy of a Nobel-Winning Innovation

The lobotomy’s effects varied wildly. Some patients showed reduced anxiety or agitation. Many others experienced catastrophic outcomes: profound apathy, inability to plan or think abstractly, incontinence, seizures, and death. Patients often lost the essence of their personalities—the qualities that made them who they were.

Rosemary Kennedy, sister of President John F. Kennedy, underwent a lobotomy in 1941 at age 23. The procedure left her incapacitated for the rest of her life, unable to speak intelligibly or care for herself. Her case, though kept private for decades, eventually became one of the most well-known examples of lobotomy’s devastating potential.

The procedure’s popularity declined rapidly in the late 1950s and 1960s. The development of chlorpromazine and other antipsychotic medications offered alternatives that didn’t require destroying brain tissue. Growing awareness of patients’ rights and mounting evidence of poor outcomes turned medical opinion against the practice. By the 1970s, lobotomies had essentially ceased in most developed nations.

The Nobel Prize Controversy Through History

The Nobel Prize has never been revoked, though the organization acknowledges that some awards appear misguided in hindsight. Moniz’s prize remains one of the most controversial in Nobel history. Critics argue that the award should be rescinded or at least formally acknowledged as a mistake. Defenders note that the prize reflected the medical understanding of its era and that rescinding it would set a problematic precedent.

The Nobel Foundation maintains that its prizes represent judgments made at a specific moment in history, not eternal truths. Other controversial medical Nobel Prizes include the 1926 award for malaria fever therapy to treat syphilis—a dangerous treatment quickly superseded by antibiotics. These awards remind us that scientific consensus evolves and that today’s breakthroughs may become tomorrow’s cautionary tales.

Frequently Asked Questions

Why did the Nobel Committee award the prize for lobotomy?

In 1949, the lobotomy appeared to offer hope for patients with severe, untreatable mental illnesses. Before antipsychotic medications existed, psychiatric institutions had few tools beyond restraints and sedation. The Nobel Committee believed Moniz had discovered a genuine therapeutic intervention, though this judgment was based on incomplete evidence and would prove tragically wrong.

How many people received lobotomies?

Estimates suggest that between 40,000 and 50,000 lobotomies were performed in the United States alone, with tens of thousands more performed internationally. The exact global number remains unknown because many procedures went unrecorded or records were later destroyed. Peak usage occurred during the 1940s and 1950s.

Are lobotomies still performed today?

Traditional lobotomies are no longer performed. However, highly refined psychosurgical procedures targeting very specific brain areas are occasionally used as absolute last resorts for severe, treatment-resistant conditions like obsessive-compulsive disorder. These modern procedures bear little resemblance to historical lobotomies and involve precise targeting with minimal tissue damage.

Did António Egas Moniz face consequences for his role in lobotomy?

Moniz died in 1955, before the full extent of lobotomy’s harms became widely recognized. He never faced professional consequences and remained respected in Portugal until his death. Ironically, he was shot and partially paralyzed by one of his patients in 1939, though not a lobotomy patient. The ethical reckoning with his legacy came after his lifetime.

The lobotomy stands as a sobering reminder that scientific consensus can be spectacularly wrong and that prestigious recognition doesn’t guarantee lasting value. This chapter in medical history teaches humility—a lesson worth remembering as we evaluate today’s cutting-edge treatments that future generations might judge with equal horror.

Sources

• The Nobel Prize – Physiology or Medicine 1949
• Encyclopaedia Britannica – Lobotomy and Psychosurgery
• National Center for Biotechnology Information – History of Psychosurgery